Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Medicine, Cerebrospinal fluid, Biomarker, Dementia, Frontotemporal dementia, and Disease.
Fluid biomarkers for neurodegenerative diseases: a comprehensive update
Amyloid pathology and vascular risk are associated with distinct patterns of cerebral white matter hyperintensities: A multicenter study in 3132 memory clinic patients
CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
Strategic white matter hyperintensity locations for cognitive impairment: A multicenter lesion‐symptom mapping study in 3525 memory clinic patients
Amyloid processing in <scp>COVID</scp>‐19‐associated neurological syndromes
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease
Dementia wellbeing and COVID‐19: Review and expert consensus on current research and knowledge gaps
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes
Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study
Loss and dispersion of superficial white matter in Alzheimer’s disease: a diffusion MRI study
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome
Imaging biomarkers in neurodegeneration: current and future practices
Relevance of biomarkers across different neurodegenerative diseases
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg
Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest
Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic
Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imaging
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
Differences in hippocampal subfield volume are seen in phenotypic variants of early onset Alzheimer's disease
CSF neurogranin or tau distinguish typical and atypical Alzheimer disease
Navigational cue effects in Alzheimer's disease and posterior cortical atrophy
Music models aberrant rule decoding and reward valuation in dementia
Music Perception in Dementia
Dissecting IWG-2 typical and atypical Alzheimer’s disease: insights from cerebrospinal fluid analysis
Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?
Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals